Yüklüyor......
Maintenance therapy in non-small-cell lung cancer
With standard doublet chemotherapy for patients with advanced non-small-cell lung cancer (NSCLC), we have reached an outcome plateau of about 10 months median overall survival over the last decades. Several studies have now demonstrated some survival benefits for patients treated beyond induction ch...
Kaydedildi:
| Yayımlandı: | Transl Lung Cancer Res |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Pioneer Bioscience Publishing Company
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367569/ https://ncbi.nlm.nih.gov/pubmed/25806166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2011.10.02 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|